Cox CS Jr, Notrica DM, Juranek J, Miller JH, Triolo F, Kosmach S, Savitz SI, Adelson PD, Pedroza C, Olson SD, Scott MC, Kumar A, Aertker BM, Caplan HW, Jackson ML, Gill BS, Hetz RA, Lavoie MS, Ewing-Cobbs L. Autologous bone marrow mononuclear cells to treat severe traumatic brain injury in children. Brain. 2024 May 3;147(5):1914-1925. PubMed PMID: 38181433
Bedi SS, Scott MC, Skibber MA, Kumar A, Caplan HW, Xue H, Sequeira D, Speer AL, Cardenas F, Gudenkauf F, Uray K, Srivastava AK, Prossin AR, Cox CS Jr. PET imaging of microglia using PBR28suv determines therapeutic efficacy of autologous bone marrow mononuclear cells therapy in traumatic brain injury. Sci Rep. 2023 Sep 26;13(1):16142. PubMed PMID: 37752232
Gottlieb A, Toledano-Furman N, Prabhakara KS, Kumar A, Caplan HW, Bedi S, Cox CS Jr, Olson SD. Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations. Sci Rep. 2022 Apr 15;12(1):6289. PubMed PMID: 35428862
Cox CS Jr, Juranek J, Kosmach S, Pedroza C, Thakur N, Dempsey A, Rennie K, Scott MC, Jackson M, Kumar A, Aertker B, Caplan H, Triolo F, Savitz SI. Autologous cellular therapy for cerebral palsy: a randomized, crossover trial. Brain Commun. 2022;4(3):fcac131. PubMed PMID: 35702731
Caplan HW, Prabhakara KS, Toledano Furman NE, Zorofchian S, Martin C, Xue H, Olson SD, Cox CS Jr. Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model. PLoS One. 2021;16(5):e0251601. PubMed PMID: 34038436
Caplan HW, Prabhakara KS, Toledano Furman NE, Zorofchian S, Kumar A, Martin C, Xue H, Olson SD, Cox CS Jr. Combination therapy with Treg and mesenchymal stromal cells enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy. Stem Cells. 2021 Mar;39(3):358-370. PubMed PMID: 33368792
Caplan HW, Prabhakara KS, Kumar A, Toledano-Furman NE, Martin C, Carrillo L, Moreno NF, Bordt AS, Olson SD, Cox CS Jr. Human cord blood-derived regulatory T-cell therapy modulates the central and peripheral immune response after traumatic brain injury. Stem Cells Transl Med. 2020 Aug;9(8):903-916. PubMed PMID: 32383348
Caplan HW, Cardenas F, Gudenkauf F, Zelnick P, Xue H, Cox CS, Bedi SS. Spatiotemporal Distribution of Microglia After Traumatic Brain Injury in Male Mice. ASN Neuro. 2020 Jan-Dec;12:1759091420911770. PubMed PMID: 32146827
Toledano Furman N, Gottlieb A, Prabhakara KS, Bedi S, Caplan HW, Ruppert KA, Srivastava AK, Olson SD, Cox CS Jr. High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis. Sci Rep. 2020 Jul 20;10(1):11991. PubMed PMID: 32686718
Caplan H, Olson SD, Kumar A, George M, Prabhakara KS, Wenzel P, Bedi S, Toledano-Furman NE, Triolo F, Kamhieh-Milz J, Moll G, Cox CS Jr. Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application. Front Immunol. 2019;10:1645. PubMed PMID: 31417542
Bedi SS, Aertker BM, Liao GP, Caplan HW, Bhattarai D, Mandy F, Mandy F, Fernandez LG, Zelnick P, Mitchell MB, Schiffer W, Johnson M, Denson E, Prabhakara K, Xue H, Smith P, Uray K, Olson SD, Mays RW, Cox CS Jr. Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury. J Neuroinflammation. 2018 Mar 16;15(1):84. PubMed PMID: 29548333
Liras IN, Caplan HW, Stensballe J, Wade CE, Cox CS, Cotton BA. Prevalence and Impact of Admission Acute Traumatic Coagulopathy on Treatment Intensity, Resource Use, and Mortality: An Evaluation of 956 Severely Injured Children and Adolescents. J Am Coll Surg. 2017 Apr;224(4):625-632. PubMed PMID: 28131925
Caplan HW, Cox CS, Bedi SS. Do microglia play a role in sex differences in TBI?. J Neurosci Res. 2017 Jan 2;95(1-2):509-517. PubMed PMID: 27870453